AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SOLSTICE MINERALS LTD

0.335

+0.0051.52%

Volume:1.55K

Turnover:503.00

Market Cap:37.92M

PE:-11.03

High:0.335

Open:0.325

Low:0.325

Close:0.330

52wk High:0.410

52wk Low:0.140

Shares:113.20M

Float Shares:87.12M

Volume Ratio:0.02

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.030

EPS(LYR):-0.030

ROE:-14.96%

ROA:-11.16%

PB:1.86

PE(LYR):-11.03

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

SELLAS Life Sciences Group (SLS): Valuation Check After Positive Phase 2 Data for SLS009 in AML

Simply Wall St.

Sellas Life Says Phase 2 Study of Cancer Combination Treatment Shows 'Clinically Meaningful' Activity; Shares Up Pre-Bell

MT Newswires Live

Sellas Life Sciences Raises $31 Million From Exercise of Warrants

MT Newswires Live

NASA has a wild plan to return astronauts to the moon. Here’s why experts are starting to worry

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SLS.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SLS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SLS.AU\",,,,,undefined,":{"symbol":"SLS.AU","market":"AU","secType":"STK","nameCN":"SOLSTICE MINERALS LTD","latestPrice":0.335,"timestamp":1765516320000,"preClose":0.33,"halted":0,"volume":1546,"delay":0,"nameEN":"SOLSTICE MINERALS LTD","floatShares":87123024,"shares":113203297,"eps":-0.030362,"marketStatus":"Market Closed","change":0.005,"latestTime":"12-12 16:12:00 AEDT","open":0.325,"high":0.335,"low":0.325,"amount":503,"amplitude":0.030303,"askPrice":0.335,"askSize":49977,"bidPrice":0.325,"bidSize":42767,"shortable":3,"etf":0,"ttmEps":-0.030362,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1765753200000},"marketStatusCode":7,"adr":0,"listingDate":1651327200000,"exchange":"ASX","adjPreClose":0.33,"openAndCloseTimeList":[[1765494000000,1765515600000]],"volumeRatio":0.015052997082935194,"lotSize":0,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SLS.AU\",,,,,undefined,":{"symbol":"SLS.AU","floatShares":87123024,"roa":"-11.16%","roe":"-14.96%","lyrEps":-0.030362,"volumeRatio":0.015052997082935194,"shares":113203297,"dividePrice":0,"high":0.335,"amplitude":0.030303,"preClose":0.33,"low":0.325,"week52Low":0.14,"pbRate":"1.86","week52High":0.41,"institutionHeld":0,"latestPrice":0.335,"committee":-0.077741,"eps":-0.030362,"divideRate":0,"volume":1546,"delay":0,"ttmEps":-0.030362,"open":0.325,"prevYearClose":0.155,"prevWeekClose":0.34,"prevMonthClose":0.295,"prevQuarterClose":0.37,"fiveDayClose":0.34,"twentyDayClose":0.285,"sixtyDayClose":0.37},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SLS.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SLS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SLS.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2590533441","title":"SELLAS Life Sciences Group (SLS): Valuation Check After Positive Phase 2 Data for SLS009 in AML","url":"https://stock-news.laohu8.com/highlight/detail?id=2590533441","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590533441?lang=en_us&edition=fundamental","pubTime":"2025-12-10 21:29","pubTimestamp":1765373348,"startTime":"0","endTime":"0","summary":"SELLAS Life Sciences Group (SLS) is back on traders radar after announcing positive Phase 2 data for SLS009 in combination therapy for tough to treat acute myeloid leukemia patients with myelodysplastic changes.\nSee our latest analysis for SELLAS Life Sciences Group.\nThe upbeat Phase 2 readout has added fresh fuel to a stock that was already in motion, with a 1 day share price return of 4.40 percent and year to date share price return of 77.57 percent. The 1 year total shareholder return of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sls/sellas-life-sciences-group/news/sellas-life-sciences-group-sls-valuation-check-after-positiv","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sls/sellas-life-sciences-group/news/sellas-life-sciences-group-sls-valuation-check-after-positiv","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SLS","BK7104","SLS.AU","BK4139"],"gpt_icon":0},{"id":"2589362143","title":"Sellas Life Says Phase 2 Study of Cancer Combination Treatment Shows 'Clinically Meaningful' Activity; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2589362143","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589362143?lang=en_us&edition=fundamental","pubTime":"2025-12-08 17:45","pubTimestamp":1765187112,"startTime":"0","endTime":"0","summary":"Sellas Life Sciences Group  said Sunday that results of an ongoing phase 2 study of SLS009 in combination with azacitidine and venetoclax showed \"clinically meaningful\" activity in patients with relapsed or refractory acute myeloid leukemia, a type of cancer.Among the 35 evaluable patients, the overall response rate was 46%. Patients harboring ASXL1 or TP53 mutations achieved response rates of 48% and 57%, respectively. The company said the median overall survival was \"exceedingly higher\" than the expected 2.6 months in this patient population.The results didn't show any dose-limiting toxicities or treatment-related deaths, and the combination was well tolerated, according to Sellas.The company's shares were up 8.1% in recent premarket activity Monday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK7104","SLS","SLS.AU"],"gpt_icon":0},{"id":"2578426776","title":"Sellas Life Sciences Raises $31 Million From Exercise of Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2578426776","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578426776?lang=en_us&edition=fundamental","pubTime":"2025-10-27 21:44","pubTimestamp":1761572646,"startTime":"0","endTime":"0","summary":"Sellas Life Sciences Group  said Monday an institutional investor exercised warrants to purchase up to around 22.4 million shares for gross cash proceeds of about $31 million.The investor will receive new registered warrants to purchase up to around 22.4 million shares at an exercise price of $2.00, which will be exercisable immediately and expire five years from the date of issuance, the company said.The transaction is expected to close on or about Tuesday, Sellas said.Shares of the company were down more than 2% in early trading Monday.Price: 1.94, Change: -0.05, Percent Change: -2.51","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SLS.AU","SLS","BK7104","BK4139"],"gpt_icon":0},{"id":"2575322733","title":"NASA has a wild plan to return astronauts to the moon. Here’s why experts are starting to worry","url":"https://stock-news.laohu8.com/highlight/detail?id=2575322733","media":"Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575322733?lang=en_us&edition=fundamental","pubTime":"2025-10-14 01:57","pubTimestamp":1760378220,"startTime":"0","endTime":"0","summary":"Calls for the United States to return astronauts to the moon before the end of the decade have been increasingly loud and frequent, emanating from bipartisan lawmakers and science advocates alike. But underlying that drumbeat is a quagmire of epic proportions.","market":"nz","thumbnail":"https://www.bnnbloomberg.ca/resizer/v2/DHLMT7JNABEKXGXH63J2HFURZY.JPG?smart=true&auth=81f46fb7b0598a5b1b6ca420d36ac1b347f659447debe86f45f1351501e01eb2&width=500&height=333","type":0,"news_type":0,"thumbnails":["https://www.bnnbloomberg.ca/resizer/v2/DHLMT7JNABEKXGXH63J2HFURZY.JPG?smart=true&auth=81f46fb7b0598a5b1b6ca420d36ac1b347f659447debe86f45f1351501e01eb2&width=500&height=333"],"rights":{"source":"bnn_bloomberg_highlight","url":"https://www.bnnbloomberg.ca/business/international/2025/10/13/nasa-has-a-wild-plan-to-return-astronauts-to-the-moon-heres-why-experts-are-starting-to-worry/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bnnbloomberg.ca/business/international/2025/10/13/nasa-has-a-wild-plan-to-return-astronauts-to-the-moon-heres-why-experts-are-starting-to-worry/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bnn_bloomberg_highlight","symbols":["SLS.AU","BK4139","BK7104","DXYZ","SLS","UFO"],"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SLS.AU\",params:#limit:6,delay:true,,,undefined,":[]}}